Thoracic Surgical Oncology: Maintaining a High-Volume Surgical Program During the COVID-19 Pandemic.
Where this comes from
- Record sourced from PubMed, PMID 32511989.
- Also identified by DOI 10.1016/j.athoracsur.2020.05.017 and PMC identifier 7274087.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Thoracic surgical oncology is a time-sensitive, high-resource, complex surgical speciality to which coronavirus has posed a unique challenge. In response to the evolving situation in mainland Europe, our department rapidly established a coronavirus disease 2019-free site to maintain elective cancer surgery. This necessitated a strict admission pathway and perioperative patient management. It resulted in the maintenance of a high-volume, high-quality thoracic surgical oncology program with no coronavirus disease 2019-positive cases to date. Maintaining satisfactory training levels among surgical and anesthetic trainees has also been achieved. We suggest that this model could be adapted to local resource capabilities.
Medical subject headings
- Betacoronavirus
- Coronavirus Infections
- Neoplasms
- Pneumonia, Viral
- Program Evaluation
- Surgical Oncology
- Thoracic Surgery
- Thoracic Surgical Procedures